A client receives a new prescription for montelukast. Which information should the nurse include in the client's teaching?
The medication will contract the smooth muscles located in the respiratory tract.
Montelukast will help repair damaged tissue in the base of the lungs.
The medication will prophylactically limit the inflammatory response to allergens.
Montelukast will increase the production of mucus in the lungs.
The Correct Answer is C
A) Montelukast does not directly contract smooth muscles in the respiratory tract. Instead, it helps reduce inflammation and bronchoconstriction.
B) Montelukast does not repair damaged lung tissue. It primarily addresses the inflammatory component of asthma and allergies.
The information the nurse should include in the client's teaching about montelukast is:
C) The medication will prophylactically limit the inflammatory response to allergens.
Explanation:
Montelukast is a leukotriene receptor antagonist used to manage and prevent asthma symptoms and allergies. It works by blocking the action of leukotrienes, which are chemicals in the body that contribute to inflammatory responses. By limiting the inflammatory response to allergens, montelukast helps reduce symptoms like wheezing, coughing, shortness of breath, and allergic rhinitis.
D) Montelukast does not increase the production of mucus in the lungs. In fact, it can help reduce excessive mucus production associated with allergic reactions and asthma.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Measure the client's urinary output:
Measuring urinary output may be necessary for other reasons, but it is not the primary action needed when a client report darkening of urine due to carbidopa/levodopa.
B. Obtain a specimen for a urine culture:
Obtaining a urine culture is not warranted when the change in urine color is likely due to medication side effects and there are no signs of infection or abnormal urinary symptoms.
C. Encourage an increase in oral intake:
Encouraging increased oral intake may be appropriate for various reasons, such as maintaining hydration, but it is not specifically related to the change in urine color caused by carbidopa/levodopa.
When a client with Parkinson's disease who is taking carbidopa/levodopa reports that their urine appears to be darker in color, the nurse should take the following action:
D. Explain the color change is normal.
Explanation: The darkening of urine can be a normal side effect of carbidopa/levodopa. Levodopa, one of the medications in this combination drug, can cause a darkening of urine, sweat, or saliva. It's essential for the nurse to reassure the client that this is a known and typically harmless side effect of the medication. There is usually no need for further evaluation or intervention in response to this change in urine color.
Correct Answer is B
Explanation
A. Lorazepam:
Lorazepam is a benzodiazepine used for its anxiolytic and sedative effects. It is not known to cause AKI. Monitoring for sedation and respiratory depression may be necessary, but this is unrelated to kidney function.
The client the nurse should closely monitor for the development of acute kidney injury (AKI) when administering medications is:
B. Vancomycin.
Explanation: Vancomycin, an antibiotic commonly used to treat bacterial infections, has the potential to cause nephrotoxicity (kidney damage), especially when given in high doses or over a prolonged period. Therefore, clients receiving vancomycin should be closely monitored for signs of AKI, including changes in urine output, serum creatinine levels, and other renal function indicators.
C. Sucralfate:
Sucralfate is a medication used to treat and prevent gastrointestinal ulcers. It is not typically associated with AKI. Monitoring for gastrointestinal side effects is more relevant when administering sucralfate.
D. Digoxin:
Digoxin is a medication used to treat heart conditions. While it can affect renal function, it is not a primary cause of AKI. Monitoring serum digoxin levels and assessing for signs of digoxin toxicity are important when administering digoxin, but it is not the primary concern for AKI.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
